E. Janulionis

发表

Postgraduate Cancer Education and Training in Lithuania: Harmonization According to the EU Rules

N. Samalavicius, Ramunė Mineikytė, E. Janulionis, 2015, Journal of Cancer Education.

E3 ubiquitin ligases as drug targets and prognostic biomarkers in melanoma.

K. Bielskienė, L. Bagdonienė, B. Kazbarienė, 2015, Medicina.

Lack of Activity of Orally Administered Clofazimine against Intracellular Mycobacterium tuberculosis in Whole-Blood Culture

Ho-Yeon Song, R. Wallis, Carolina Sofer, 2004, Antimicrobial Agents and Chemotherapy.

Acute toxicity and quality of life in high risk prostate cancer patients: Updated results of randomized hypofractionation trial.

E. Aleknavičius, K. Valuckas, E. Janulionis, 2018, Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology.

The changes of radiotherapy in Lithuania: infrastructure, utilization rate, and cost

A. Plieskienė, Ramunė Mineikytė, E. Janulionis, 2016, Acta medica Lituanica.

Survival and Replication of Clinical Mycobacterium tuberculosis Isolates in the Context of Human Innate Immunity

B. Kreiswirth, E. Shashkina, R. Wallis, 2005, Infection and Immunity.

The Impact of the COVID-19 Pandemic on Cancer Patient’s Management—Lithuanian Cancer Center Experience

V. Ostapenko, S. Cicėnas, V. Urbonas, 2021, Healthcare.

Californium versus cobalt brachytherapy combined with external-beam radiotherapy for IIB stage cervical cancer: long-term experience of a single institute

K. Valuckas, E. Janulionis, V. Atkočius, 2015, Journal of contemporary brachytherapy.

Androgen-deprivation therapy and risk of death from cardio-vascular disease in prostate cancer patients: a nationwide lithuanian population-based cohort study

G. Smailytė, M. Kincius, E. Janulionis, 2022, The aging male : the official journal of the International Society for the Study of the Aging Male.

A randomized trial comparing hypofractionated and conventionally fractionated three-dimensional conformal external-beam radiotherapy for localized prostate adenocarcinoma: a report on the first-year biochemical response.

A. Plieskienė, K. Valuckas, E. Janulionis, 2009, Medicina.

A randomized hypofractionation dose escalation trial for high risk prostate cancer patients: interim analysis of acute toxicity and quality of life in 124 patients

G. Storme, B. Engels, M. de Ridder, 2013, Radiation Oncology.

Second primary malignancies after high-dose-rate 60Co photon or 252Cf neutron brachytherapy in conjunction with external-beam radiotherapy for endometrial cancer.

M. Rivard, K. Valuckas, E. Janulionis, 2018, Brachytherapy.

Investigation of Vitamin D-Binding Protein Polymorphism Impact on Coronary Artery Disease and Relationship with Longevity: Own Data and a Review

R. Benetis, A. Ulys, D. Stakišaitis, 2016, International journal of endocrinology.

Analysis of cardiac and pulmonary complication probabilities after radiation therapy for patients with early-stage breast cancer.

K. Valuckas, E. Janulionis, J. Berzins, 2009, Medicina.

252 Cf neutron brachytherapy and external 60 Co photon therapy in the curative management of primary or recurrent rectal cancer

J. Kurtinaitis, K. Valuckas, E. Janulionis, 2005 .

Cf neutron brachytherapy and external 60 Co photon therapy in the curative management of primary or recurrent rectal cancer

J. Kurtinaitis, K. Valuckas, E. Janulionis, 2005 .

A randomized hypofractionation dose escalation trial for high risk prostate cancer patients: interim analysis of acute toxicity and quality of life in 124 patients

G. Storme, B. Engels, M. de Ridder, 2013, Radiation oncology.

Efficacy of focal high-dose-rate brachytherapy in the treatment of patients diagnosed with low or favourable intermediate-risk prostate cancer—a protocol for a randomised controlled trial

J. Venius, G. Smailytė, M. Trakymas, 2023, BMJ Open.

Strain specificity of antimycobacterial immunity in whole blood culture after cure of tuberculosis.

R. Wallis, S. Vinhas, E. Janulionis, 2009, Tuberculosis.

Long-Term Results In Cervical And Uterine Cancer Patients Treated With Combined Photon And Neutron Radiotherapy

K. Valuckas, E. Janulionis, V. Atkočius, 2016 .

Second primary malignancies after radiotherapy including HDR (252)Cf brachytherapy for cervical cancer.

M. Rivard, K. Valuckas, E. Janulionis, 2015, Brachytherapy.

Long Term Results in Cervical Cancer Patients Treated with Radiotherapy

K. Valuckas, E. Janulionis, V. Atkočius, 2014 .

Clinical Study of Adaptive Prostate Brachytherapy with I-125 Implants Based on Radiological Findings. Results on Early and Late Toxicity and Ongoing Challenges

S. Letautiene, E. Aleknavičius, A. Ulys, 2014 .

Long-term results for Stage IIIB cervical cancer patients receiving external beam radiotherapy combined with either HDR (252)Cf or HDR (60)Co intracavitary brachytherapy.

M. Rivard, K. Valuckas, E. Janulionis, 2016, Brachytherapy.

The 99mTc-MIP-1404 PSMA Uptake in the Isolated Paratracheal Lymph Node From the Prostate Adenocarcinoma

E. Janulionis, S. Tiškevičius, J. Jonušas, 2022, Clinical Nuclear Medicine.

Development of a benchmark tool for cancer centers; results from a pilot exercise

Wineke A. M. van Lent, W. V. van Harten, I. Nefkens, 2018, BMC Health Services Research.

Postgraduate Cancer Education and Training in Lithuania: Harmonization According to the EU Rules

N. Samalavicius, Ramunė Mineikytė, E. Janulionis, 2015, Journal of Cancer Education.

Lack of Activity of Orally Administered Clofazimine against Intracellular Mycobacterium tuberculosis in Whole-Blood Culture

Ho-Yeon Song, R. Wallis, Carolina Sofer, 2004, Antimicrobial Agents and Chemotherapy.